Results 51 to 60 of about 12,001 (129)
Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes
Introduction: Semaglutide (SEMA) has shown potential benefits in metabolic dysfunction-associated steatotic liver disease (MASLD). This large real-world study aimed to evaluate the effects of SEMA on MASLD patients’ clinical outcomes and liver-related ...
Mohamad Suki +14 more
doaj +1 more source
ABSTRACT Background In 2023 and 2024, research into semaglutide (SEMA), an antiobesity and antidiabetic medication, indicated potential benefits beyond its approved uses, particularly in preventing Alzheimer's disease (AD). This highlights the link between obesity and AD development.
Amene Saghazadeh +14 more
wiley +1 more source
This study aimed to develop an effective oral formulation of semaglutide, a glucagon-like peptide-1 receptor agonist, using an organometallic phyllosilicate-based colonic delivery system.
Gyu Lin Kim +2 more
doaj +1 more source
ABSTRACT This paper examines the moral dilemmas faced by street‐level bureaucrats (SLBs) as they engage in aspiration management while providing integration services to migrants and refugees. European integration policies prioritise rapid employment, often directing refugees toward low‐skilled jobs, which may conflict with their higher professional and
Ihssane Otmani +2 more
wiley +1 more source
Potential Role of Semaphorin 3A and Its Receptors in Regulating Aberrant Sympathetic Innervation in Peritoneal and Deep Infiltrating Endometriosis. [PDF]
Previous studies have demonstrated the involvement of nerve repellent factors in regulation of the imbalanced innervation of endometriosis. This prospective study aims to explore the role of Sema 3A in regulating aberrant sympathetic innervation in ...
Yanchun Liang +8 more
doaj +1 more source
Risk factors for cholera mortality: A scoping review
Abstract Objectives Cholera is an easily treatable disease, but many people are still unnecessarily dying from it. To improve current case management practices and prevent mortality requires a comprehensive understanding of who is at higher risk of dying.
Despina Pampaka +4 more
wiley +1 more source
Abstract figure legend Four weeks of semaglutide treatment causes significant reductions in total body weight, fat mass, lean mass, and grip strength in mice with diet induced obesity. Mice treated with semaglutide lost a greater amount of total body weight and fat mass compared to mice fed fed a calorie matched diet.
S. Jeromson +12 more
wiley +1 more source
Abstract Family Album follows a young university student assisting a journalist in documenting a glass workers' strike in Istanbul's Paşabahçe neighborhood during the summer of 1999. Immersed in the atmosphere of solidarity and collective struggle, she accompanies the journalist to interview Murat, a key strike organizer, in his shanty house ...
Deniz Yonucu
wiley +1 more source
This study evaluated the effects of increasing levels of cactus pear (Opuntia spp.) included in haylage of Senna obtusifolia on intake, ingestive behavior, nutrient digestibility, nitrogen balance, ruminal and blood parameters, and performance of fattening sheep.
Bernadin Fonrose +9 more
wiley +1 more source
Mitochondrial Adaptations in Skeletal Muscle Following Incretin‐Based Therapies: In Vitro
ABSTRACT Background Incretin‐based therapies such as glucagon‐like peptide‐1 receptor agonists (GLP‐1Ras), dual GLP‐1/GIP agonists and amylin analogues have demonstrated significant weight loss benefits. However, their impact on skeletal muscle mitochondrial function, particularly under metabolic stress, remains unclear. This study aimed to investigate
Victoria Old +6 more
wiley +1 more source

